Fidson Healthcare shareholders have approved a ₦3.6 billion dividend after the company posted a record ₦119.06 billion annual revenue, becoming Nigeria’s first pharmaceutical firm to surpass the ₦100 billion revenue milestone. Wengglobal examines the significance for investors and Africa’s healthcare industry.
Tag: Nigeria pharmaceutical industry
NAFDAC Blacklists Onifam Laboratories, Directors Over Regulatory Breaches, Bans Future Pharmaceutical Operations in Nigeria!
NAFDAC has blacklisted Onifam Laboratories Limited and its directors over regulatory violations, banning them from all pharmaceutical business in Nigeria as part of intensified efforts to strengthen drug safety, regulatory compliance, and public health protection.